Samarkand Group PLC - owner of specialist health and healing brands - Calls general meeting for May 2 to ask shareholders to approve the company’s de-listing from Aquis Stock Exchange and re-registration as a private company. If approved, its shares will be cancelled from trading on May 7. Samarkand notes that since its founding in 2016, it has changed its strategy from one of introducing Western brands to consumers in China to one of owning differentiated health and healing brands. Samarkand cites costs, lack of liquidity, and inability to access capital as reasons for giving up its AQSE listing. The decision already has 77% support from all shareholders and 65% of independent shareholders.

Following the de-listing, Samarkand shares will be available to trade for at least 12 months on the JP Jenkins matched bargain facility. JP Jenkins separately notes on Tuesday that 10 new companies joined its platform during March. This gives it 49 total constituents with a combined market capitalisation of £1.84 billion.

Current stock price: quoted on AQSE on Tuesday at 3.50 pence; last traded on Monday at 2.50p; £2.0 million market capitalisation

12-month change: flat from 2.50p

Copyright 2025 Alliance News Ltd. All Rights Reserved.